Licensed Practical Nurse in Waterford, PA Accepting Medicare

3 Licensed Practical Nurse nurses found. Showing 1 - 3

Mrs. Kelly Lynn Eicher, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2626 Laurie Dr, Waterford, PA 16441 Phone: 814-882-0693

Sarah Lynn Peters, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2501 Mclaughlin Rd, Waterford, PA 16441 Phone: 814-392-1465    Fax: 814-455-9440

Theresa Louise Holland, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1957 Bagdad Rd, Waterford, PA 16441 Phone: 814-796-4081

News Archive

AGA's journals highlight important updates into treatments for cirrhosis, NAFLD

Cirrhosis and nonalcoholic fatty liver disease (NAFLD) are two serious liver conditions with limited pharmacological treatments. The December issues of AGA's journals - Clinical Gastroenterology and Hepatology and Gastroenterology - highlight important updates into treatments for these two debilitating diseases.

Botox injections relieve severe facial pain

According to a doctor in Brazil the excruciating pain associated with inflammation of the trigeminal nerve of the head and face can be substantially relieved by injections of botulinum toxin A.

Increased stress hormones accelerate breast cancer metastasis

It has long been thought that stress contributes to cancer progression. Scientists from the University of Basel and the University Hospital of Basel have deciphered the molecular mechanisms linking breast cancer metastasis with increased stress hormones.

Combining inhibitor drug with immunotherapy agent improves response in cancer patients

Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe, and may benefit some patients with advanced cancers that have not responded to traditional therapy, according to results of a phase 1 clinical trial led by researchers at the Johns Hopkins Kimmel Cancer Center, Bloomberg~Kimmel Institute for Cancer Immunotherapy and several other centers including University of Pittsburgh Cancer Institute, Yale Cancer Center and City of Hope in Los Angeles, which participated in study enrollment, and the University of Southern California and University College Cork in Ireland, which collaborated on analysis of the data.

AVEO announces results from tivozanib Phase 1b clinical trial for advanced gastrointestinal cancers

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced results from a Phase 1b clinical trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with FOLFOX6, a standard chemotherapy regimen, in patients with advanced gastrointestinal (GI) cancers.

Read more Medical News

› Verified 6 days ago